in particular with concomitant gastroduodenal pathology;cardiac disturbances;depressive disturbances;Parkinson's disease and Parkinson's disease-like pathology;temperature disturbances;bone impairments;hypertension-induced various organ damages;disturbances of coagulation;pain disturbances;convulsion disorders;spinal cord injury;alcohol injuries, induced by alcohol abuse or increased alcohol intake;brain ischemic disorders;peripheral nerve injuries;cataleptic disorders and neuroleptic disturbances;disorders related to abnormal or mutant lymphocytes;disturbances of fetuses;vaginal atrophy and osteoporosis development caused by ovariectomy conditions;tumors;viral diseases, in particular AIDS or ARC;gastrointestinal lesions;cognitive disorders;withdrawal disturbances;kidney disturbances anddisturbances in cellular immune response
Cardiovascular Protection: Heart Health Benefits Beyond Weight Loss The SUSTAIN-6 trial, a landmark cardiovascular outcomes study, showed that semaglutide reduced the risk of major adverse cardiac eventsincluding heart attack, stroke, and cardiovascular deathby 26% compared to placebo in people with type 2 diabetes
However, the effectiveness of oral glutathione remains controversial due to its breakdown by stomach enzymes
On the other hand, semaglutide has specific approvals for lowering cardiovascular risk in certain patients
Other adenovirus-based therapies, including advexin and SCH-58500, have shown promising results in clinical trials
